As Sequencing Continues to Scale, Volta Labs Improves Sample Prep: Udayan Umapathi, CEO
Description
Depending on your age, DNA sequencing is experiencing a second or third renaissance. New sequencing tools continue to make genomics one of the fastest-growing industries of all time. All this scaling can create a bottleneck in sample prep. Volta Labs, a company founded out of the MIT Media Lab by Udayan Umapathi, has just commercialized a new instrument for sample prep called Callisto. The instrument manipulates samples with electric, magnetic, and acoustic fields.
Udayan joins us today to describe the new instrument and comment on how sample prep is evolving today. Most importantly, the company wants to develop new apps with customized settings based on the customer's particular application, such as isolating really long, high-molecular-weight DNA for long-read sequencing.
“The vision is to have a vast set of apps, similar to an iPhone. We will continue to provide more and more apps that cater to various customers,” says Udayan in today’s show.
What are the apps Udayan sees in the next few years? And what is the ultimate sample prep in today’s world of sequencing?
This is a public episode. If you’d like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Coming from the field of digital pathology, Joachim Schmid has a unique perspective on the evolution of multi-omics. Schmid was recently appointed as Vice President of Multiomics Data Solutions at Illumina.In this episode, Theral dives into the burgeoning field of multi-omics—integrating data...
Published 11/21/24
Dr. Mark Lewis is a well known GI oncologist at Intermountain Health in Salt Lake City, Utah. Gifted with a passionate communication style, he has over 93,000 Twitter followers. Next month, he will live-tweet his upcoming colonoscopy.
In this episode, Dr. Lewis joins Theral in our ongoing...
Published 11/14/24